Although glucuronidation is considered an important pathway in aromatic amine-induced bladder cancer, benzidine glucuronidation has not been assessed in humans. Glucuronidation of benzidine was assessed with human liver microsomes and slices. Emulgen 911-treated microsomes exhibited a Km for benzidine of 0.8 +/- 0.06 mM and a Vmax of 4.2 +/- 0.7 nmol/mg protein/min. A variety of agents were tested for their ability to inhibit benzidine N-glucuronide formation. At 0.25 mM, estriol, 17-epiestriol, bilirubin, hyodeoxycholic acid and cyproheptadine were good inhibitors (< 50% of control). Dose-dependent inhibition studies with estriol, testosterone and 4-aminobiphenyl demonstrated that each agent reached a plateau as its concentration was increased. When these agents were combined at maximal inhibitory concentrations, additive inhibition was observed. These results suggest that more than one UDP-glucuronosyltransferase metabolizes benzidine. The cDNA clones pUDPGTh-1 and -2 encode transferases which metabolize hyodeoxycholic acid and estrogen derivatives, but neither transferase catalyzed benzidine glucuronidation. Slices were used to assess metabolism by intact tissue and converted [3H]benzidine (0.09 mM) to N-acetyl-benzidine. N-Glucuronides of both benzidine and N-acetylbenzidine were observed and represented 14-37% of the total recovered radioactivity. The amount of N-acetylbenzidine N'-glucuronide observed was proportional to the amount of N-acetylbenzidine produced. Thus, N-glucuronidation appears to represent a major pathway for metabolism of benzidine in humans. The extent of N-acetylation affects the proportion of benzidine and N-acetylbenzidine glucuronidated by human liver slices.
[1]
S. R. Babu,et al.
Benzidine glucuronidation in dog liver.
,
1993,
Carcinogenesis.
[2]
S. R. Babu,et al.
Role of N-glucuronidation in benzidine-induced bladder cancer in dog.
,
1992,
Carcinogenesis.
[3]
R. Lubet,et al.
Two human liver cDNAs encode UDP-glucuronosyltransferases with 2 log differences in activity toward parallel substrates including hyodeoxycholic acid and certain estrogen derivatives.
,
1992,
Biochemistry.
[4]
M. Green,et al.
N-glucuronidation of carcinogenic aromatic amines catalyzed by rat hepatic microsomal preparations and purified rat liver uridine 5'-diphosphate-glucuronosyltransferases.
,
1987,
Cancer research.
[5]
J. Miller,et al.
Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis.
,
1977,
Cancer research.
[6]
E. Bingham,et al.
Benzidine exposure as a cause of bladder tumors.
,
1973,
Archives of environmental health.
[7]
M. E. Hosker,et al.
Tumours of the Urinary Bladder
,
1936,
The Indian Medical Gazette.
[8]
R. Hayes,et al.
Mortality and incidence of bladder cancer in benzidine-exposed workers in China.
,
1992,
American journal of industrial medicine.
[9]
L. Spry,et al.
Metabolism and disposition of benzidine in the dog.
,
1990,
Carcinogenesis.